These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8608976)
1. Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis. Maurizi M; Almadori G; Cadoni G; Scambia G; Ottaviani F; Ferrandina G; Paludetti G; D'Abramo G; Mancuso S Int J Cancer; 1996 Apr; 69(2):105-9. PubMed ID: 8608976 [TBL] [Abstract][Full Text] [Related]
2. Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. Paksoy M; Hardal U; Caglar C J Cancer Res Clin Oncol; 2011 Sep; 137(9):1371-7. PubMed ID: 21789704 [TBL] [Abstract][Full Text] [Related]
3. Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status. Ferrandina G; Scambia G; Benedetti Panici P; Almadori G; Paludetti G; Cadoni G; Distefano M; Maurizi M; Mancuso S Cancer Lett; 1992 Dec; 67(2-3):133-8. PubMed ID: 1483262 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and immunoradiometric evaluations of total cathepsin D in human larynx. Marsigliante S; Biscozzo L; Resta L; Leo G; Mottaghi A; Maiorano E; Colucci G; Storelli C Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):51-5. PubMed ID: 9135974 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients. Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of Cath-D and CD44 in laryngeal squamous cell carcinomas]. Wu H; Wang W; Xu L Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 May; 12(5):195-7. PubMed ID: 11189153 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of cathepsin D in primary ovarian cancer. Scambia G; Panici PB; Ferrandina G; Salerno G; D'Agostino G; Distefano M; de Vincenzo R; Ercoli A; Mancuso S Eur J Cancer; 1994; 30A(7):935-40. PubMed ID: 7946587 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Almadori G; Cadoni G; Galli J; Ferrandina G; Scambia G; Exarchakos G; Paludetti G; Ottaviani F Int J Cancer; 1999 Apr; 84(2):188-91. PubMed ID: 10096253 [TBL] [Abstract][Full Text] [Related]
10. [The expression of Cath-D, c-erbB-2 and EGFR in breast cancer and its correlation to lymphatic metastasis]. Xu L; Shen Z; Zhu W Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):60-3. PubMed ID: 7656792 [TBL] [Abstract][Full Text] [Related]
11. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters. Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study. Kristensen GB; Holm R; Abeler VM; Tropé CG Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388 [TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L. Hantschmann P; Beysiegel S; Kurzl R J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260 [TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Xie M; Sun Y; Li Y Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854 [TBL] [Abstract][Full Text] [Related]
15. The potential prognostic value of cathepsin D protein in serous ovarian cancer. Chai Y; Wu W; Zhou C; Zhou J Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353 [TBL] [Abstract][Full Text] [Related]
16. [Patterns and prognostic factors of cervical lymph node metastasis in supraglottic laryngeal carcinoma]. Li X; Di B; Shao Y; Shang Y; Cheng J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):707-10. PubMed ID: 15831037 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis and prognostic value of cathepsin D determination in laryngeal squamous cell carcinoma. Seiwerth S; Stambuk N; Konjevoda P; Masić N; Vasilj A; Bura M; Klapan I; Manojlović S; Danić D J Chem Inf Comput Sci; 2000; 40(3):545-9. PubMed ID: 10850757 [TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck. Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J Anticancer Res; 2000; 20(5C):3975-81. PubMed ID: 11268487 [TBL] [Abstract][Full Text] [Related]
20. [Cathepsin D: an independent prognostic factor in cancer of the breast]. Romain S; Muracciole X; Varette I; Bressac C; Brandone H; Martin PM Bull Cancer; 1990; 77(5):439-47. PubMed ID: 2400813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]